<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font27 { font-size : 27; } .font28 { font-size : 28; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">group </span>
   <span class="font28">EPO </span>
   <span class="font27">patients </span>
   <span class="font21">control </span>
   <span class="font21">study </span>
   <span class="font20">EASI </span>
   <span class="font20">skin </span>
   <span class="font19">.±. </span>
   <span class="font19">oil </span>
   <span class="font18">effect </span>
   <span class="font18">score </span>
   <span class="font17">primrose </span>
   <span class="font17">{border-style </span>
   <span class="font16">significant </span>
   <span class="font16">experimental </span>
   <span class="font16">px;} </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">Dermatol </span>
   <span class="font16">Korean </span>
   <span class="font16">acid </span>
   <span class="font16">atopic </span>
   <span class="font16">conducted </span>
   <span class="font16">evening </span>
   <span class="font16">group. </span>
   <span class="font15">month </span>
   <span class="font15">placebo </span>
   <span class="font15">.±., </span>
   <span class="font15">clinical </span>
   <span class="font15">difference </span>
   <span class="font15">GLA </span>
   <span class="font15">fatty </span>
   <span class="font15">showed </span>
   <span class="font14">group, </span>
   <span class="font14">hydration </span>
   <span class="font14">months </span>
   <span class="font14">improvement </span>
   <span class="font14">significantly </span>
   <span class="font14">vs. </span>
   <span class="font13">dermatitis </span>
   <span class="font13">mild </span>
   <span class="font13">(.~.) </span>
   <span class="font13">Atopic </span>
   <span class="font13">Fig. </span>
   <span class="font13">placebo-controlled </span>
   <span class="font13">present </span>
   <span class="font13">Evening </span>
   <span class="font13">TEWL </span>
   <span class="font13">eczema </span>
   <span class="font13">randomized, </span>
   <span class="font13">studies </span>
   <span class="font13">study. </span>
   <span class="font12">AD. </span>
   <span class="font12">IgE </span>
   <span class="font12">decreased </span>
   <span class="font12">groups </span>
   <span class="font12">improved </span>
   <span class="font12">mean </span>
   <span class="font12">p=.) </span>
   <span class="font12">p=.). </span>
   <span class="font12">px; </span>
   <span class="font12">value </span>
   <span class="font12">{font-family </span>
   <span class="font12">TEWL, </span>
   <span class="font12">beginning </span>
   <span class="font12">blood </span>
   <span class="font12">changes </span>
   <span class="font12">double-blinded, </span>
   <span class="font12">font-size </span>
   <span class="font12">placebo. </span>
   <span class="font12">results </span>
   <span class="font12">using </span>
   <span class="font12">(EPO) </span>
   <span class="font12">(experimental </span>
   <span class="font12">Clin </span>
   <span class="font12">GLA, </span>
   <span class="font12">Kim </span>
   <span class="font12">acids </span>
   <span class="font12">adverse </span>
   <span class="font12">comparison </span>
   <span class="font12">disease </span>
   <span class="font12">double; </span>
   <span class="font12">intake </span>
   <span class="font12">measurement </span>
   <span class="font12">performed </span>
   <span class="font12">shown </span>
   <span class="font12">systemic </span>
   <span class="font12">treatment </span>
   <span class="font11">(IU/ml) </span>
   <span class="font11">EPO. </span>
   <span class="font11">Hallym </span>
   <span class="font11">However, </span>
   <span class="font11">Korea </span>
   <span class="font11">University </span>
   <span class="font11">administered </span>
   <span class="font11">baseline </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">capsules </span>
   <span class="font11">deficiency </span>
   <span class="font11">essential </span>
   <span class="font11">feeling </span>
   <span class="font11">hydration, </span>
   <span class="font11">males </span>
   <span class="font11">measured </span>
   <span class="font11">pruritus </span>
   <span class="font11">score, </span>
   <span class="font11">solid; </span>
   <span class="font11">therapeutic </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">.±.; </span>
   <span class="font11">AD, </span>
   <span class="font11">Ann </span>
   <span class="font11">Area </span>
   <span class="font11">Changes </span>
   <span class="font11">Eczema </span>
   <span class="font11">Essential </span>
   <span class="font11">Park </span>
   <span class="font11">Review </span>
   <span class="font11">Severity </span>
   <span class="font11">VAS </span>
   <span class="font11">age </span>
   <span class="font11">anti-inflammatory </span>
   <span class="font11">arachidonic </span>
   <span class="font11">bold </span>
   <span class="font11">borage </span>
   <span class="font11">cause </span>
   <span class="font11">concentration </span>
   <span class="font11">containing </span>
   <span class="font11">courier; </span>
   <span class="font11">em; </span>
   <span class="font11">evaluated </span>
   <span class="font11">females) </span>
   <span class="font11">immunosuppressant, </span>
   <span class="font11">including </span>
   <span class="font11">increase </span>
   <span class="font11">inflammatory </span>
   <span class="font11">itch </span>
   <span class="font11">omega- </span>
   <span class="font11">patient </span>
   <span class="font11">patients. </span>
   <span class="font11">pt;} </span>
   <span class="font11">received </span>
   <span class="font11">related </span>
   <span class="font11">severity </span>
   <span class="font11">statistical </span>
   <span class="font11">statistically </span>
   <span class="font11">study, </span>
   <span class="font11">subjective </span>
   <span class="font11">supplementation </span>
   <span class="font11">transepidermal </span>
   <span class="font11">values </span>
   <span class="font11">verified </span>
   <span class="font11">water </span>
  </p>
 </body>
</html>
